Manager

The Senior Manager, SRHR - HIV, TB and Innovative Financing will lead a portfolio of catalytic investment opportunities to improve access, affordability and supply security for priority HIV, TB and SRHR products and delivery models. The role sits at the intersection of strategy, markets and transaction execution, working with manufacturers, procurement platforms, governments, investors and global health institutions to translate access barriers into practical financing structures that support improved health outcomes in low- and middle-income countries.

The role combines investment pipeline development with hands-on deal execution, identifying where catalytic capital can address market failures and selecting the financing instruments, partners and commercial terms needed to make investments viable. This may include prefinance facilities, procurement guarantees, working capital facilities, volume commitments, recoverable grants and private sector outcomes funds.

The role offers breadth across market shaping, commodity financing, manufacturer partnerships, investment structuring, procurement reform and transition planning across CIFF’s HIV, TB and SRHR portfolio. The role is expected to maintain a prioritised transaction pipeline and take approximately three to five deals from concept to approval or launch annually, with an indicative aggregate value of US$25-50 million, subject to portfolio need, partner readiness and available capital.

Principal responsibilities

Investment Pipeline Development

• Identify and originate catalytic investment opportunities across CIFF’s HIV, TB and SRHR portfolio that can improve access, affordability, supply security and cost-effective scale.
• Develop investment theses for priority diagnostics, pharmaceuticals, devices and manufacturing partnerships, including the access problem, market failure, financing gap, expected impact and CIFF’s catalytic role.
• Assess product introduction, procurement, manufacturing, technology transfer and supply-side market-shaping barriers to determine where catalytic investment can unlock faster, more affordable scale.
• Design early-stage deal concepts, including the rationale, partner demand, proposed instrument, expected impact, risk-sharing approach and pathway to execution.
• Build and maintain a prioritised pipeline of investable transactions, with sufficient depth to support approximately three to five approvals or launches per year, subject to strategic fit, additionality, partner demand, execution feasibility and potential to scale beyond CIFF funding.

Deal Execution

• Lead transaction execution for approved investments, from concept refinement and partner engagement with private and public sector partners through due diligence, financial modelling, approvals, contracting, launch and performance monitoring.
• Structure investments using appropriate instruments, including recoverable grants, guarantees, concessional debt, equity-like instruments, milestone-based payments, volume commitments and outcome-linked payments.
• Negotiate commercial terms with manufacturers, investors, DFIs, procurement platforms and delivery partners, balancing price, access, risk allocation, performance milestones, governance and transition arrangements.
• Work with Legal, Finance, Grants Management and programme colleagues to ensure catalytic investment deals are executable, compliant, commercially robust and aligned with CIFF’s objectives.
• Prepare investment papers, decision memos and financial analyses that clearly set out strategic fit, expected impact, cost-effectiveness, risks and trade-offs.

Product Access Strategy & Market Shaping

• Work with the Senior Manager, Product Introduction & Market Development to translate product-specific access barriers into investable market-shaping priorities, including registration, demand generation, route to market, procurement readiness, manufacturing capacity and affordability.
• Assess manufacturer economics, supplier constraints, quality assurance pathways, technology transfer requirements and LMIC market-entry barriers to identify where CIFF capital or influence can change access outcomes.
• Define the access conditions that catalytic investment should secure, including price, volume, geography, timelines, supply reliability, quality requirements and commitments to low- and middle-income country availability.
• Engage manufacturers, the Global Fund, regional procurement entities and pooled procurement platforms to understand market dynamics, demand signals and procurement bottlenecks before a transaction is structured.
• Ensure proposed deals support product introduction and market development objectives, rather than operating as standalone financing exercises disconnected from adoption, delivery and long-term scale.
• Capture lessons from priority product access efforts to inform future investment theses, access conditions and market-shaping strategies across the HIV, TB and SRHR portfolio.

Sustainability & Transition

• Embed affordability, cost-effectiveness and long-term sustainability into financing structures so that investments support progressive country ownership and durable scale.
• Engage Ministries of Health and Finance, donors and financing partners on co-financing arrangements, government financing commitments and transition milestones linked to CIFF-supported investments.
• Assess how procurement systems, budget execution, fiscal constraints and public finance processes affect the feasibility and sustainability of catalytic investment deals.
• Support country self-reliance and donor transition planning where this is directly linked to financing solutions, including pathways for governments to assume recurrent costs over time.

Membership of the team

•  This role does not hold direct line management responsibility but is expected to provide leadership, coaching and technical guidance across the portfolio. The role operates within a matrix structure and will influence investment decisions across a large and complex portfolio.

Requirements

Essential Skills & Experience

• Significant experience in investment banking, private equity, venture capital, development finance, strategic investments, impact investing, commercial transactions, global health financing or management consulting.
• Strong transaction execution skills, including investment origination, due diligence, financial modelling, investment appraisal, deal structuring, negotiation, contracting and portfolio monitoring.
• Demonstrated experience originating, structuring, negotiating and executing complex financing transactions, commercial partnerships or investment deals, including blended finance and procurement-linked instruments such as volume guarantees, revolving funds, access funds, subsidies, working capital facilities or direct investment structures.
• Experience assessing manufacturer partnerships, supply-side market shaping, local or regional manufacturing, technology transfer, quality assurance, WHO prequalification or regulatory pathways for diagnostics, pharmaceuticals, medical devices or other global health products.
• Strong understanding of global health markets, procurement platforms, access barriers, supplier economics and the role of catalytic capital in shaping markets for priority health products.
• Strong financial modelling, investment appraisal, commercial analysis, forecasting and data visualization capabilities.
• Experience presenting recommendations to senior executives, Boards or Investment Committees.

Desirable Experience

• Experience working with global health financing institutions, DFIs, or Ministries of Finance and Health.
• Exposure to market shaping, procurement or sustainable transition planning in global health.
• Exposure to strategic investment, impact investment or social finance models used by organisations such as strategic investment funds, access-finance entities or health investment platforms, including guarantees, debt, equity, volume commitments and risk-sharing mechanisms.
• Experience supporting country self-reliance agendas, domestic resource mobilization, transition planning or co-financing arrangements in global health.

Key working relationships

• Internal: SRHR Executive Director, Directors, Programme Managers, Manager Product Introduction & Market Development, Finance, Legal, Grants Management, Partnerships and External Affairs.
• External: Global Fund, World Bank, regional development banks, DFIs, Ministries of Finance, Ministries of Health, bilateral donors, philanthropies, regional procurement entities, manufacturers of diagnostics, pharmaceuticals and devices, access-finance platforms, investors and financial institutions.

Management dimensions

• No direct budget or people management accountability but contributes the efficient operation of their team.

Benefits

The starting salary for this role is £82,000.

CIFF operates a hybrid work policy across all locations, which means employees work in the office and some of the time from home. We are happy to provide more information on this as part of the recruitment process.

Alongside a competitive salary, we offer a generous benefits package here at CIFF that includes, but is not limited to the following.

• Annual leave - 25 days per annum. Increasing by 1 day after each year of service to a maximum of 30 days.
• Bonus - CIFF currently operates a discretionary bonus scheme.
• Training allowance
• Wellbeing allowance
• Life insurance
• Medical insurance

Please submit your application on or before Tuesday 20 October 2026. CIFF reserves the right to close the job advert early if we receive a high number of suitable applications.

Building and harnessing diversity of perspective and experience within CIFF is critical to us achieving our bold goals. We strive to deliver a work environment which is diverse, equitable and inclusive, respecting and embracing individual differences and needs, and enabling all members of the CIFF family to be at their best. We consistently work to enhance our policies and practices, ensuring that they actively support this intent. Our flexible, hybrid model of working seeks to accommodate the individual needs of our people and enhance employee wellbeing.